Science
U.S. surgeon general on vaccinations delay
Surgeon General Dr. Jerome Adams joins "CBS This Morning" to discuss why there was a delay in COVID-19 vaccinations in the U.S.
Watch CBS News
Surgeon General Dr. Jerome Adams joins "CBS This Morning" to discuss why there was a delay in COVID-19 vaccinations in the U.S.
Across the country, small pharmacies are quickly becoming a vital part of the COVID-19 vaccine distribution. They're stepping up to combat misinformation and administer the vaccine in areas where medical resources and accessibility is often limited. Mireya Villarreal reports from Texas.
The United Kingdom is battling an acute outbreak, recording more than 50,000 new coronavirus infections a day over the past six days. The new COVID variant is up to 70% more contagious.
The race is on to end the pandemic with global immunization, but the world is hardly an equal place. Elizabeth Palmer has more on the struggles to get the vaccine to everyone.
With the coronavirus raging at an all-time high, health officials are expecting an increase in virus infections from holiday gatherings in December. Jonathan Vigliotti reports.
Some experts predict the next month could be the worst part of the pandemic so far in the U.S., after millions of people traveled for the holidays. The new, more transmissible COVID-19 variant — first detected in the U.K. — is now in the states, and vaccinations are happening much more slowly than predicted. Dr. Stanley Perlman joins CBSN's Lana Zak to discuss the latest on the pandemic.
Scott Gottlieb, former chief of the Food and Drug Administration, said the vaccine should be made it available for 75 and above first, followed by 70 and older, and 65 and above.
Moncef Slaoui, the chief adviser to Operation Warp Speed, said 17.5 million doses of coronavirus vaccines have shipped so far in the U.S.
AARP CEO Jo Ann Jenkins says "we're not moving fast enough" to administer COVID-19 vaccines to elderly residents at long-term care facilities.
The former FDA commissioner says the government should make the vaccine more widely available to older populations.